|Print Page Email Page RSS Email Alerts Tear Sheet|
“Alkermes is honored to be included in this important national dialogue.
We are encouraged by the level of engagement by senior policymakers and
public health officials to evaluate the treatment status quo and
consider new treatment approaches to help address the opioid epidemic,”
said Richard Pops, Chief Executive Officer of
Please click here to read a corporate statement on the testimony.
About Opioid Dependence
A chronic brain disease, opioid dependence is characterized by cognitive, behavioral and physiological symptoms in which an individual continues to use opioids despite significant harm to oneself and others.1 The use of heroin, an illegal opioid drug, and the non-medical use of
2 SAMHSA. Behavioral Health Trends in
Sandy Coombs, +1 781-609-6377
Eva Stroynowski, +1 781-609-6823
Jennifer Snyder, +1 781 609-6166